TrademarkOpen
Search / United States / 98290658

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

HAPRULO

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and…
Show more

Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, and brain disorders

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 29 Nov 2023
    Application filed
    New Application Entered
  2. 27 Jun 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 28 Jun 2024
    Approved for publication
    Approved For Pub - Principal Register
  4. 6 Aug 2024
    Published for opposition
    Published For Opposition
  5. 1 Oct 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 2 Oct 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 14 Aug 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  8. 4 Feb 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 27 events
2026-08-04Notice Of Approval Of Extension Request E-Mailed
2026-08-03Sou Teas Extension Received
2026-08-03Sou Extension 4 Filed
2026-08-03Sou Extension 4 Granted
2026-05-14Notice Of Approval Of Extension Request E-Mailed
2026-02-04Sou Teas Extension Received
2026-02-04Sou Extension 3 Filed
2026-02-04Sou Extension 3 Granted
2025-08-15Notice Of Approval Of Extension Request E-Mailed
2025-08-14Sou Teas Extension Received
2025-08-14Sou Extension 2 Filed
2025-08-14Sou Extension 2 Granted
2024-10-02Sou Teas Extension Received
2024-10-02Sou Extension 1 Filed
2024-10-02Sou Extension 1 Granted
2024-10-02Notice Of Approval Of Extension Request E-Mailed
2024-10-01Noa Mailed - Sou Required From Applicant
2024-08-06Published For Opposition
2024-08-06Official Gazette Publication Confirmation E-Mailed
2024-07-17Notification Of Notice Of Publication E-Mailed
2024-06-28Approved For Pub - Principal Register
2024-06-27Assigned To Examiner
2024-03-12Teas Change Of Owner Address Received
2024-03-12Applicant/Correspondence Changes (Non-Responsive) Entered
2024-03-12Teas Change Of Correspondence Received
2024-02-17New Application Office Supplied Data Entered
2023-11-29New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, and brain disorders

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 4 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.